Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Nelfinavir for the Treatment of Kaposi Sarcoma

NCT03077451 is registered in ClinicalTrials.gov with AIDS Malignancy Consortium as lead sponsor.

NCT NCT03077451
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03077451 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Nelfinavir for the Treatment of Kaposi Sarcoma
Lead sponsor
AIDS Malignancy Consortium
Phase
Phase 2
Overall status
Completed
Start date
March 13, 2017
Completion date
April 13, 2023
Enrollment
36 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent kaposi sarcoma, skin kaposi sarcoma